Sectors & Industries HealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2026)
Top pharmaceutical stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best pharmaceutical stocks to buy now. Learn More.

Industry: Drug Manufacturers - Spec...

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Pharmaceutical is Zen Rated B and is the 34th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
AMRX	AMNEAL PHARMACEUTICALS INC	$3.93B	-68.00%	2.00%	11.60%	8.60%	-52.97	2.17	36.90%	2.40%	10.75%
INDV	INDIVIOR PHARMACEUTICALS INC	$3.81B	-99.20%	15.40%	98.95%	80.70%	-13.27	0.71	80.10%	16.90%	22.92%
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	$34.59B	20.00%	3.50%	7.93%	9.50%	4.15	1.04	51.80%	8.20%	12.54%
PAHC	PHIBRO ANIMAL HEALTH CORP	$2.25B	30.80%	6.70%	14.96%	10.10%	3.23	3.05	31.90%	6.30%	11.47%
LNTH	LANTHEUS HOLDINGS INC	$4.92B	20.60%	10.80%	17.61%	28.60%	1.04	2.70	61.10%	15.20%	21.64%
ELAN	ELANCO ANIMAL HEALTH INC	$11.47B	-3.50%	-1.70%	-0.03%	-0.10%	1.04	2.17	55.00%	-4.90%	-0.08%
TAK	TAKEDA PHARMACEUTICAL CO LTD	$59.20B	1.60%	0.80%	4.45%	7.00%	1.02	1.19	65.30%	2.50%	12.75%
SUPN	SUPERNUS PHARMACEUTICALS INC	$2.91B	-3.70%	-2.80%	-4.40%	-15.30%	0.37	1.91	89.60%	-5.40%	-6.82%
VTRS	VIATRIS INC	$15.47B	-23.00%	-9.20%	-10.61%	-14.50%	1.53	1.38	35.10%	-24.60%	-22.33%
NBIX	NEUROCRINE BIOSCIENCES INC	$13.21B	16.70%	11.60%	18.14%	20.00%	0.42	3.39	98.20%	16.70%	24.66%
KMDA	KAMADA LTD	$488.60M	7.70%	5.40%	7.34%	18.10%	0.41	4.07	42.30%	11.20%	13.48%
IRWD	IRONWOOD PHARMACEUTICALS INC	$577.23M	-8.20%	6.60%	66.44%	16.30%	-2.52	1.13	100.00%	8.10%	34.70%
ZTS	ZOETIS INC	$49.79B	58.20%	18.10%	27.07%	25.70%	3.64	3.03	71.80%	28.20%	37.84%
CPIX	CUMBERLAND PHARMACEUTICALS INC	$47.41M	-10.50%	-4.00%	-5.74%	-9.90%	2.10	1.01	85.00%	-6.40%	-5.17%
ORGO	ORGANOGENESIS HOLDINGS INC	$288.16M	7.80%	3.90%	8.96%	12.60%	0.55	3.62	75.60%	3.50%	7.92%
ESPR	ESPERION THERAPEUTICS INC	$670.28M	N/A	-6.00%	38.63%	11.90%	-2.54	1.54	67.90%	-5.60%	15.82%
ANIP	ANI PHARMACEUTICALS INC	$1.66B	16.20%	5.60%	9.97%	12.30%	1.66	2.71	61.40%	8.70%	13.11%
PCRX	PACIRA BIOSCIENCES INC	$976.58M	0.90%	0.50%	3.00%	3.10%	0.83	4.54	79.40%	1.00%	4.72%
BHC	BAUSCH HEALTH COMPANIES INC	$1.98B	-20.50%	0.60%	9.05%	7.80%	-46.91	1.47	70.70%	1.50%	19.56%
HLN	HALEON PLC	$44.45B	10.20%	5.00%	8.67%	24.40%	0.98	0.92	64.20%	15.10%	21.77%
ETON	ETON PHARMACEUTICALS INC	$681.84M	-18.80%	-4.80%	-1.57%	-2.70%	2.52	1.57	53.90%	-5.70%	-1.04%
COLL	COLLEGIUM PHARMACEUTICAL INC	$1.03B	24.10%	3.90%	14.38%	19.10%	4.49	1.57	59.30%	8.10%	22.41%
SCYX	SCYNEXIS INC	$39.66M	-19.00%	-14.40%	-15.83%	-21.20%	0.20	7.04	100.00%	-41.80%	-40.95%
DERM	JOURNEY MEDICAL CORP	$135.29M	-46.40%	-13.20%	-13.43%	-37.40%	1.97	1.79	66.20%	-18.50%	-12.40%
LFCR	LIFECORE BIOMEDICAL INC	$143.91M	N/A	N/A	N/A	N/A	-13.95	3.49	N/A	N/A	N/A
AMPH	AMPHASTAR PHARMACEUTICALS INC	$927.82M	12.80%	6.00%	10.14%	11.10%	1.07	4.02	49.50%	13.60%	20.71%
EBS	EMERGENT BIOSOLUTIONS INC	$426.07M	9.60%	3.70%	11.98%	11.50%	1.52	5.01	56.10%	7.10%	19.13%
TKNO	ALPHA TEKNOVA INC	$169.34M	-23.30%	-15.80%	-17.17%	-14.40%	0.51	4.58	33.20%	-42.60%	-40.70%
CRON	CRONOS GROUP INC	$959.00M	-0.90%	-0.80%	-5.54%	-23.60%	0.05	19.59	42.80%	-6.40%	-43.39%
YCBD	CBDMD INC	$7.69M	-64.60%	-34.50%	-26.22%	-97.00%	0.31	2.94	60.60%	-19.50%	-12.37%
PBH	PRESTIGE CONSUMER HEALTHCARE INC	$2.48B	10.20%	5.40%	9.19%	21.60%	0.91	3.11	56.10%	16.90%	27.94%
EOLS	EVOLUS INC	$262.19M	N/A	-23.30%	-20.77%	-17.50%	-10.78	1.90	66.30%	-17.40%	-10.52%
HROW	HARROW INC	$1.31B	-10.00%	-1.40%	7.52%	10.60%	6.62	2.20	75.10%	-1.90%	8.38%
HCM	HUTCHMED (CHINA) LTD	$2.69B	45.70%	30.20%	36.41%	45.60%	0.41	4.96	38.70%	83.30%	95.42%
PRGO	PERRIGO CO PLC	$1.49B	-35.20%	-14.80%	-15.40%	-18.70%	1.91	2.76	35.10%	-33.50%	-27.24%
ASRT	ASSERTIO HOLDINGS INC	$123.81M	-30.30%	-10.60%	-19.26%	-28.30%	1.84	1.70	70.20%	-25.60%	-22.63%
RGC	REGENCELL BIOSCIENCE HOLDINGS LTD	$15.23B	-54.80%	-50.50%	-70.39%	-83.50%	0.18	7.39	N/A	N/A	N/A
SIGA	SIGA TECHNOLOGIES INC	$375.42M	11.20%	10.00%	15.08%	73.70%	0.10	11.83	68.60%	24.60%	32.12%
RDY	DR REDDYS LABORATORIES LTD	$11.11B	18.40%	12.80%	21.76%	28.70%	0.47	1.92	58.50%	17.40%	24.24%
ALKS	ALKERMES PLC	$5.81B	14.50%	10.60%	15.63%	27.10%	0.37	3.55	86.70%	16.40%	20.58%
RMTI	ROCKWELL MEDICAL INC	$37.71M	-15.60%	-9.60%	-8.81%	-11.90%	0.55	3.98	16.90%	-7.70%	-6.05%
OGI	ORGANIGRAM GLOBAL INC	$186.48M	4.90%	3.30%	1.01%	1.60%	0.44	2.73	35.60%	6.50%	1.57%
QNTM	QUANTUM BIOPHARMA LTD	$15.47M	-417.60%	-188.70%	-500.85%	-9,217.00%	0.88	1.07	N/A	N/A	N/A
CRDL	CARDIOL THERAPEUTICS INC	$141.36M	-238.00%	-165.00%	-188.25%	808.50%	0.32	4.16	N/A	N/A	N/A
TLRY	TILRAY BRANDS INC	$763.39M	-86.90%	-64.60%	-79.57%	-129.40%	0.35	2.79	27.70%	-156.70%	-168.48%
EVO	EVOTEC SE	$920.33M	-18.10%	-8.50%	-8.37%	-8.40%	1.22	2.12	10.80%	-21.00%	-15.47%
BIOA	BIOAGE LABS INC	$776.65M	-27.90%	-25.50%	-29.08%	-98.60%	0.08	14.24	100.00%	-896.10%	-888.36%
AQST	AQUESTIVE THERAPEUTICS INC	$504.05M	N/A	-64.50%	-59.11%	-49.80%	-5.77	3.14	58.30%	-188.10%	-149.70%
ALVO	ALVOTECH	$1.14B	-11.90%	2.00%	24.14%	12.80%	-6.23	1.89	60.00%	4.70%	48.49%
CGC	CANOPY GROWTH CORP	$377.86M	-52.90%	-32.70%	-32.28%	-40.00%	0.46	5.34	25.80%	-117.30%	-116.88%
IXHL	INCANNEX HEALTHCARE INC	$34.64M	-113.30%	-101.90%	-65.84%	-1,772.00%	0.02	48.27	N/A	N/A	N/A
SXTC	CHINA SXT PHARMACEUTICALS INC	$1.46M	-50.30%	-30.90%	-41.06%	4,390.00%	0.30	4.37	654,226.10%	-4,820,590.80%	-4,550,441.85%
ACB	AURORA CANNABIS INC	$195.08M	-20.60%	-14.00%	-15.21%	-17.60%	0.39	3.06	34.50%	-30.20%	-25.65%
CABR	CARING BRANDS INC	$13.70M	-217.10%	-202.40%	-291.12%	-2,166.20%	0.11	13.16	55.60%	-148,948.80%	-148,494.07%
ZYBT	ZHENGYE BIOTECHNOLOGY HOLDING LTD	$41.66M	N/A	N/A	N/A	N/A	0.47	1.49	N/A	N/A	N/A
BFRI	BIOFRONTERA INC	$11.42M	-1,139.00%	-52.20%	-60.35%	-120.20%	1.73	1.52	73.70%	-25.30%	-24.12%
IMCC	IM CANNABIS CORP	$2.00M	-498.70%	-27.90%	340.31%	-73.40%	-9.48	0.67	17.70%	-20.70%	-14.11%
APUS	APIMEDS PHARMACEUTICALS US INC	$23.64M	-139.60%	-102.80%	-61.93%	-990.20%	0.13	8.34	N/A	N/A	N/A
ZSTK	ZEROSTACK CORP	$13.66M	-332.00%	-192.10%	-98.25%	-199.70%	0.85	1.01	4.60%	-335.60%	-334.89%
GELS	GELTEQ LTD	$7.27M	-43.00%	-31.50%	-29.63%	-7,184.60%	0.36	0.27	30.30%	-4,011.90%	-2,834.31%
CTOR	CITIUS ONCOLOGY INC	$62.06M	-55.20%	-24.00%	-34.19%	-44.40%	0.88	0.83	80.00%	-599.30%	-565.79%
SHPH	SHUTTLE PHARMACEUTICALS HOLDINGS INC	$4.24M	-444.90%	-188.80%	-464.35%	625.00%	3.65	0.06	N/A	N/A	N/A
RDHL	REDHILL BIOPHARMA LTD	$0.00	N/A	-46.10%	269.50%	86.10%	-5.17	0.56	64.50%	-97.50%	-110.40%
BGM	BGM GROUP LTD	$2.44M	-2.40%	-2.10%	-3.78%	-20.90%	0.13	1.82	19.40%	-10.10%	-25.89%
UPC	UNIVERSE PHARMACEUTICALS INC	$1.78M	-7.20%	-5.40%	-6.13%	-12.00%	0.24	4.07	35.30%	-20.60%	-19.26%
TLPH	TALPHERA INC	$36.14M	-118.00%	-62.20%	-55.15%	-67.40%	0.75	5.49	100.00%	-51,035.70%	-51,035.71%
SBFM	SUNSHINE BIOPHARMA INC	$5.10M	-24.90%	-19.50%	-26.17%	-47.80%	0.30	4.21	33.00%	-16.10%	-17.41%
PRFX	PRF TECHNOLOGIES LTD	$1.74M	-96.90%	-60.80%	-53.59%	309.90%	0.32	1.78	-311.80%	-29,541.20%	-30,129.41%
KALA	KALA BIO INC	$1.40M	-2,323.90%	-87.00%	414.59%	-230.60%	-3.89	0.75	N/A	N/A	N/A
INCR	INTERCURE LTD	$35.84M	-15.90%	-9.50%	-6.43%	-8.00%	0.74	1.85	11.40%	-29.20%	-14.54%
AKAN	AKANDA CORP	$100.21k	-56.60%	-27.50%	-66.04%	-3,415.80%	0.88	1.26	9.60%	-619.50%	-619.14%
CPHI	CHINA PHARMA HOLDINGS INC	$25.53M	-28.70%	-17.00%	-13.07%	-72.70%	0.36	0.32	-3.20%	-76.90%	-74.45%
TXMD	THERAPEUTICSMD INC	$23.15M	-2.10%	-1.50%	-1.73%	-2.00%	0.40	3.02	100.00%	-18.80%	-18.83%
AYTU	AYTU BIOPHARMA INC	$28.76M	-107.20%	-19.70%	-37.96%	-254.40%	7.59	1.16	66.80%	-39.00%	-34.20%
SNOA	SONOMA PHARMACEUTICALS INC	$4.10M	-85.90%	-24.20%	-36.68%	-53.30%	2.97	2.88	38.20%	-19.00%	-19.47%

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Apr 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best pharma stocks to buy right now are:

1. Amneal Pharmaceuticals (NASDAQ:AMRX)

Amneal Pharmaceuticals (NASDAQ:AMRX) is the #1 top pharmaceutical stock out of 75 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: A, Momentum: B, Sentiment: B, Safety: C, Financials: C, and AI: C.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 35, which is 5 points higher than the pharmaceutical industry average of 30.

AMRX passed 11 out of 33 due diligence checks and has average fundamentals. Amneal Pharmaceuticals has seen its stock return 52.75% over the past year, overperforming other pharmaceutical stocks by 80 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $15.00, an upside of 20.19% from Amneal Pharmaceuticals's current stock price of $12.48.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Indivior Pharmaceuticals (NASDAQ:INDV)

Indivior Pharmaceuticals (NASDAQ:INDV) is the #2 top pharmaceutical stock out of 75 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Indivior Pharmaceuticals (NASDAQ:INDV) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Indivior Pharmaceuticals (NASDAQ:INDV) has a Due Diligence Score of 40, which is 10 points higher than the pharmaceutical industry average of 30.

INDV passed 13 out of 33 due diligence checks and has average fundamentals. Indivior Pharmaceuticals has seen its stock return 220.06% over the past year, overperforming other pharmaceutical stocks by 247 percentage points.

Indivior Pharmaceuticals has an average 1 year price target of $44.50, an upside of 46.05% from Indivior Pharmaceuticals's current stock price of $30.47.

Indivior Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Indivior Pharmaceuticals, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Teva Pharmaceutical Industries (NYSE:TEVA)

Teva Pharmaceutical Industries (NYSE:TEVA) is the #3 top pharmaceutical stock out of 75 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Teva Pharmaceutical Industries (NYSE:TEVA) is: Value: B, Growth: B, Momentum: B, Sentiment: C, Safety: B, Financials: C, and AI: B.

Teva Pharmaceutical Industries (NYSE:TEVA) has a Due Diligence Score of 24, which is -6 points lower than the pharmaceutical industry average of 30. Although this number is below the industry average, our proven quant model rates TEVA as a "A".

TEVA passed 10 out of 38 due diligence checks and has weak fundamentals. Teva Pharmaceutical Industries has seen its stock return 96.73% over the past year, overperforming other pharmaceutical stocks by 124 percentage points.

Teva Pharmaceutical Industries has an average 1 year price target of $39.00, an upside of 29.65% from Teva Pharmaceutical Industries's current stock price of $30.08.

Teva Pharmaceutical Industries stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 7 analysts covering Teva Pharmaceutical Industries, 85.71% have issued a Strong Buy rating, 14.29% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 5 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Perrigo Co (NYSE:PRGO)

Perrigo Co (NYSE:PRGO) has an annual dividend yield of 5.35%, which is 3 percentage points higher than the pharmaceutical industry average of 2.32%. Perrigo Co's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Perrigo Co's dividend has shown consistent growth over the last 10 years.

Perrigo Co's dividend payout ratio of -11.3% indicates that its high dividend yield might not be sustainable for the long-term.

2. Viatris (NASDAQ:VTRS)

Viatris (NASDAQ:VTRS) has an annual dividend yield of 3.57%, which is 1 percentage points higher than the pharmaceutical industry average of 2.32%. Viatris's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Viatris's dividend has shown consistent growth over the last 10 years.

Viatris's dividend payout ratio of -16% indicates that its dividend yield might not be sustainable for the long-term.

3. Kamada (NASDAQ:KMDA)

Kamada (NASDAQ:KMDA) has an annual dividend yield of 2.95%, which is 1 percentage points higher than the pharmaceutical industry average of 2.32%.

Kamada's dividend payout ratio of 57.1% indicates that its dividend yield is sustainable for the long-term.

Why are pharmaceutical stocks down?

Pharmaceutical stocks were down -1.19% in the last day, and up 0.83% over the last week.

We couldn't find a catalyst for why pharmaceutical stocks are down.

What are the most undervalued pharmaceutical stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued pharmaceutical stocks right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 57, which is 34 points higher than the pharmaceutical industry average of 23. It passed 4 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 145.83% in the past year. It has overperformed other stocks in the pharmaceutical industry by 173 percentage points.

2. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the second most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 29, which is 6 points higher than the pharmaceutical industry average of 23. It passed 2 out of 7 valuation due diligence checks.

Bausch Health Companies's stock has dropped -12.44% in the past year. It has overperformed other stocks in the pharmaceutical industry by 15 percentage points.

3. Collegium Pharmaceutical (NASDAQ:COLL)

Collegium Pharmaceutical (NASDAQ:COLL) is the third most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Collegium Pharmaceutical has a valuation score of 57, which is 34 points higher than the pharmaceutical industry average of 23. It passed 4 out of 7 valuation due diligence checks.

Collegium Pharmaceutical's stock has gained 7.7% in the past year. It has overperformed other stocks in the pharmaceutical industry by 35 percentage points.

Are pharmaceutical stocks a good buy now?

56.41% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 43.81% over the next year.

11.32% of pharmaceutical stocks have a Zen Rating of A (Strong Buy), 32.08% of pharmaceutical stocks are rated B (Buy), 47.17% are rated C (Hold), 7.55% are rated D (Sell), and 1.89% are rated F (Strong Sell).

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is -196.18x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.